Investments made by BII in this company:
| Investment name | Commitment | Region | Sector | Start date | Status |
|---|---|---|---|---|---|
| Investment 01 | $100m | North Africa, South Asia | Health | June 2020 | Exited |
| Investment 02 | $50m | North Africa, South Asia | Health | January 2022 | Exited |
Kelix Bio Limited
Kelix Bio (formerly Zanzibar Pharma) is a specialty generic pharmaceuticals business focused on emerging markets. The company aims to develop and commercialise affordable products in countries historically deprived of access to such medications.